The cell and gene therapy market is estimated to be valued at US$ 22.7 billion in 2023 and is expected to exhibit a CAGR of 28.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cell and gene therapy refers to a rapidly evolving field of medicine that involves the use of genetic material to treat or prevent various diseases. This cutting-edge therapy ... Read more
The cell and gene therapy market is estimated to be valued at US$ 22.7 billion in 2023 and is expected to exhibit a CAGR of 28.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cell and gene therapy refers to a rapidly evolving field of medicine that involves the use of genetic material to treat or prevent various diseases. This cutting-edge therapy ... Read more
Cell and gene therapy products are used for treatment of various genetic disorders and chronic diseases. The therapy involves modifying genes or cells that are being introduced into patient's body, to treat disease or to repair cells. Cell and gene therapy products are used for treatment of cancer, neurological disorders, cardiovascular disease, infectious diseases and other genetic disorders. The therapy holds potential to permanently cure genetic disorders by correcting faulty genes or by ... Read more
The cell and gene therapy market is transforming therapeutic landscapes and revolutionizing treatment approaches for various target diseases. Cell and gene therapy uses genetically modified or unmodified cells or nucleic acids to treat, manage or prevent diseases. These therapies aim to repair or replace damaged cells and tissues by modifying existing cells or introducing new ones. Key applications include cancer immunotherapies, genetic disorders, and cardiovascular, neurological and ... Read more
